A Phase II Multicenter Study of Visilizumab, Humanized Anti-CD3 Antibody, to Treat Steroid-Refractory Acute Graft-versus-Host Disease
Titel:
A Phase II Multicenter Study of Visilizumab, Humanized Anti-CD3 Antibody, to Treat Steroid-Refractory Acute Graft-versus-Host Disease
Auteur:
Carpenter, Paul A. Lowder, James Johnston, Laura Frangoul, Haydar Khoury, Hanna Parker, Pablo Jerome, Keith R. McCune, Jeannine S. Storer, Barry Martin, Paul Appelbaum, Frederick Abonour, Rafat Westervelt, Peter Anasetti, Claudio
Verschenen in:
Biology of blood and marrow transplantation
Paginering:
Jaargang 11 (2005) nr. 6 pagina's 7 p.
Jaar:
2005
Inhoud:
Uitgever:
American Society for Blood and Marrow Transplantation